Norgestimate And Ethinyl Estradiol Kit
Product Images NDC 68462-565

View Photos of Packaging, Regulatory Labels, and Product Appearance

Product Visual Gallery

This gallery contains 14 technical images submitted to the FDA as part of the official labeling for Norgestimate And Ethinyl Estradiol (NDC 68462-565). Unlike standard consumer photos, these assets often include clinical data figures, molecular chemical structures, and official manufacturer packaging layouts.

As provided by Glenmark Pharmaceuticals Inc., Usa, these visuals offer a comprehensive scientific overview of the product's physical and chemical identity, aiding pharmacists and researchers in product verification and study.

FDA Label Image

Blistercard1

Blistercard1
Norgestimate and EthinylEstradiol Tablets USP 0.25 mg/0.035 mg are a type of birth control pill that come in a packaging with blue and light green pills. The blue pills are active and contain the medication, while the light green pills are inactive.*
FDA Label Image

Blistercard2

Blistercard2
Norgestimate and Ethinyl Estradiol Tablets are available in three different doses, 0.18mg/0.035g, 0.215mg/0.035mg, and 0.25mg/0.035mg. The pills are white to off-white, light blue, and blue in color and are all active. There are also light green pills included in the package which are inactive. The package must be kept out of reach of children as it is not child-resistant. No further information is available from this text.*
FDA Label Image

Carton Label

Carton Label
This is a product label for a contraceptive medication containing norgestimate and ethinyl estradiol in tablet form. The dosage is one tablet per day as prescribed. It is important to note that while this product prevents pregnancy, it does not protect against HIV or other sexually transmitted diseases. The package includes detailed patient labeling and a summary patient package insert. The medication should be stored at 20-25°C (68-77°F) and protected from light. This product is not child-resistant and should be kept out of the reach of children. Manufacturing information is also included. No other information is available.*
FDA Label Image

Figure 1

Figure 1
This appears to be a table of different studies examining the risk of breast cancer associated with the use of combined oral contraceptives. The studies are listed along with the year they were conducted and the corresponding effect estimates (OR, RR, and HR). The table also includes a graph showing the effect estimates on a scale from -1.5 to 2.0.*
FDA Label Image

Figurea

Figurea
Norgestimate and EthinylEstradiol Tablets USP 0.25 mg/0.035 mg are a combination of hormones used for birth control. The tablets come in two colors, blue (active) and light green (inactive).*
FDA Label Image

Figureb

Figureb
This is a medication description for Norgestimate and Ethinyl Estradiol Tablets with different doses. The package is not child-resistant, so the medication should be kept away from children. The pills are in different colors - white to off-white, light blue, blue (all active) and light green (inactive).*
FDA Label Image

Figurec

FDA Label Image

Figured

FDA Label Image

Figuree

FDA Label Image

Figuref

FDA Label Image
FDA Label Image

Carton Label

Carton Label
This is a medication containing various dosages of norgestimate USP and ethinyl estradiol USP to prevent pregnancy. The tablets are of different colors and must be taken daily as prescribed. The medication is packaged along with a patient information leaflet. The medication should be stored at temperatures between 15°C and 30°C (59°F- 86°F) and protected from light. The manufacturer is Glenmark Pharmaceuticals Inc. The medication is available in blister cards containing 28 tablets each. Contact Glenmark Pharmaceuticals Inc. for more information.*
FDA Label Image

Structures (Chem Structures)

Structures (Chem Structures)
This text appears to be a list of chemicals or compounds. The first two lines seem to contain abbreviations and formulae, while the last two lines appear to list the names of two chemicals: "Norgestimate, USP" and "Ethiny] Estradiol, USP". It is possible that this text is related to pharmaceutical or chemical research.*
FDA Label Image

Img3 (Img3)

Img3 (Img3)
This is a chart depicting different forms of birth control methods and their effectiveness rates in preventing pregnancies. The chart shows that having fewer than one pregnancy per 100 women in a year is the most effective, while having 85 or more pregnancies per 100 women is the least effective. The chart also lists various forms of birth control methods, including implants, injections, intrauterine devices, sterilization, birth control pills, skin patch, vaginal ring with hormones, condoms, diaphragm, no sex during fertile days, spermicide, and withdrawal.*

* These product label images have been analyzed using experimental machine learning. Please verify findings with the primary label text.